Literature DB >> 8981358

Regulation of cell cycle entry and G1 progression by CSF-1.

M F Roussel1.   

Abstract

Proliferation, differentiation, and survival of monocytes, macrophages, and their immediate progenitors is regulated by the macrophage colony-stimulating factor (CSF-1). CSF-1 initiates a mitogenic response by binding to its receptor (CSF-1R), thereby activating the receptor's intrinsic tyrosine kinase activity and initiating signaling via multiple effector-mediated pathways. CSF-1 is required throughout G1 to ensure entry of bone marrow-derived macrophages into S phase, and persistent CSF-1R kinase activity is necessary to the expression of both immediate early (e.g., c-fos, c-jun, and c-myc) and delayed early (e.g., D-type cyclins) response genes. Ectopic expression of human CSF-1R in different mouse cell lines, including fibroblasts, IL-3-dependent myeloid cells, and early pre-B cells, confers CSF-1 responsiveness by replacing the cells' requirements for other mitogenic growth factors. NIH-3T3 fibroblasts engineered to express a human CSF-1 receptor point mutant (CSF-1R [Y809F]) fail to proliferate in response to CSF-1 and remain arrested in the early G1 phase of the cell cycle. Despite CSF-1-dependent transcription of fos and jun family members, c-myc, D-type, and E-type G1 cyclin mRNAs are not expressed in the latter cells in response to growth factor stimulation. However, enforced expression of c-myc or D-type cyclins, but not cyclin E, resensitizes cells bearing CSF-1R (Y809F) to the mitogenic effects of CSF-1, enabling them to proliferate continuously in liquid culture and to form colonies in agar in response to the growth factor. D-type cyclin mutants defective in binding to the retinoblastoma protein (pRB) were unable to rescue mutant receptor signaling, suggesting that the ability of D-type cyclin-dependent kinases to cancel pRB's growth-suppressive function is necessary for CSF-1-induced G1 exit. By contrast, cyclin E must function in a different pathway. Cells rescued by c-myc were prevented from entering S phase by microinjection of antibodies to cyclin D1. Conversely, cyclin D1-rescued cells were inhibited from forming CSF-1-dependent colonies in agar when challenged with either a dominant-negative c-myc mutant or mad, a transcription factor which competes with myc for max, its requisite heterodimeric partner. Thus, although the expression of c-myc and D-type cyclins is rate limiting for G1 phase progression, their functions are interdependent, with both activities being required for mitogenicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8981358     DOI: 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  11 in total

1.  Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

Authors:  N Aziz; H Cherwinski; M McMahon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression.

Authors:  A Dey; H She; L Kim; A Boruch; D L Guris; K Carlberg; S M Sebti; D T Woodley; A Imamoto; W Li
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

3.  Colony-stimulating factor-1 (CSF-1) expression in the uteroplacental unit of mice with spontaneous and induced pregnancy loss.

Authors:  M Gorivodsky; A Torchinsky; J Shepshelovich; S Savion; A Fein; H Carp; V Toder
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

4.  Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling.

Authors:  L F Fowles; M L Martin; L Nelsen; K J Stacey; D Redd; Y M Clark; Y Nagamine; M McMahon; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways.

Authors:  Lida Q Fuentes; Carlos E Reyes; José M Sarmiento; Carolina I Villanueva; Carlos D Figueroa; Javier Navarro; Carlos B González
Journal:  Cell Signal       Date:  2008-05-25       Impact factor: 4.315

6.  Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.

Authors:  Karel Otero; Isaiah R Turnbull; Pietro Luigi Poliani; William Vermi; Elisa Cerutti; Taiki Aoshi; Ilaria Tassi; Toshiyuki Takai; Samuel L Stanley; Mark Miller; Andrey S Shaw; Marco Colonna
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606

7.  The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.

Authors:  Andrea Morandi; Valentina Barbetti; Maria Riverso; Persio Dello Sbarba; Elisabetta Rovida
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

8.  A role for Cdc42 in macrophage chemotaxis.

Authors:  W E Allen; D Zicha; A J Ridley; G E Jones
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

9.  CSF-1R as an inhibitor of apoptosis and promoter of proliferation, migration and invasion of canine mammary cancer cells.

Authors:  Magdalena Król; Kinga Majchrzak; Joanna Mucha; Agata Homa; Małgorzata Bulkowska; Arleta Jakubowska; Malwina Karwicka; Karol M Pawłowski; Tomasz Motyl
Journal:  BMC Vet Res       Date:  2013-04-05       Impact factor: 2.741

10.  CSF-1 receptor-dependent colon development, homeostasis and inflammatory stress response.

Authors:  Duy Huynh; Dilara Akçora; Jordane Malaterre; Chee Kai Chan; Xu-Ming Dai; Ivan Bertoncello; E Richard Stanley; Robert G Ramsay
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.